Wi Fi Radiation as Dangerous as Microwave Weapons, warns Physicist

 By LUIS MIRANDA | THE REAL AGENDA | JULY 5, 2012

Barrie Trower, a British physicist and expert on microwave weapons warned this week about the dangers of WiFi radiation, which he says, is as dangerous as the radiation emitted by microwave weapons. Mr. Trower is not just a scientist who happened to study microwave energy as a tool for warfare, he dedicated most of his career to studying the effects what this kind of technology has on whoever and whatever is exposed to it.

Mr. Trower completed research for the Royal British Navy and military intelligence regarding the effects that microwave energy, and he decided to leave his retirement to clear up the fog about whether the radiation emitted by WiFi technology is harmless to humans, as other people have said recently. During an interview with the Toronto Star, Trower spoke about the dangers of WiFi radiation and how other household appliances also emit the same kind of energy that is also harmful to all living things.

Previous to Mr. Trower speaking out, an organization called Health Canada had publicly said that WiFi networks posed not threat to human health and that therefore it was fine to install and maintain WiFi networks in schools and other public places often visited by large amounts of people. Mr. Trower shook the validity of the report from Health Canada, by saying that the radiation frequencies emitted by WiFi signals is equal to those used in microwave weapons. In his speeches and meetings with members from Health Canada, Barrie Trower provided documentary proof in paper form where he explains how and why WiFi radiation is so dangerous to humans and specially to children.

In the document, Mr. Trower begins by providing an account of his experience studying the effects of microwave radiation and then describes how these radiation has the capacity to literally cook living things while they’re alive. “The Cold War extended my military education into the full diversity of stealth microwave warfare and communication systems. I was previously aware of reports concerning dead birds in and around communication bases. On examination these birds were found to be cooked.” Trower goes further to explain that microwave technology is the selected mode of communication in military settings because its radio waves are so strong that they are capable of penetrating places where no other form of radio waves can get.

Trower adds that sickness due to exposure to microwave radiation was first seen and reported back in 1932, when it was identified as ‘microwave or radio wave sickness’. Among the symptoms of such sickness, experts have found severe tiredness, fatigue, fitful sleep, headaches, intolerability and high susceptibility to infection. The symptoms, he says, are a consequence of the athermal effects of the radiation; that is, the effects the radiation has without emitting or exposing the victims to any kind of noticeable heat waves. In his document prepared for the Kind of Botswana, Trower cites the example of the US Embassy in Moscow, which was irradiated with low level microwave energy during the Cold War. The consequences of this radiation, says Trower, were multiple cancers, leukaemias and other illnessess that appeared among Embassy workers and their relatives.

Regading the exposition of people and especially children to low levels of Wi Fi radiation, Trower said: “That’s wrong”, as he asserted there are no safe levels of exposure to that kind of radiation. According to his research and the International Commission for Non-Ionizing Radiation Protection Guidelines, children, the elderly and people with poor health are the most likely to have less tolerance to Wi Fi radiation, that is why he considers it inadmissible to promote the installation of Wi Fi technology in highly populated areas or places like schools, where children spend a great deal of time.

Fourty years later after the effects of microwave radiation were discovered and documented, the US Naval Medical Research Institute (NMRI) documented 2300 research articles that reported over 120 illnesses originated from radio frequency and non-ionizing microwave radiation. This information was obtained through a Freedom of Information Act request and extracts of the documents confirming that the military was well aware of the dangerous effects of microwave radiation, but chose to hide that information to avoid drawbacks to commercial applications. “If the more advanced nations of the West are strict in enforcement of stringent exposure standards, there could be unfavourable effects an industrial output and military functions.”

Barrie Trower says that “children are physiologically and neurologically immature. It takes years for the blood-brain barrier to form, leaving children more prone to cell-leakage from microwave radiation.” He adds that a person’s natural immune system takes 18 years to develop, therefore children are completely unprotected against this radiation. He has visited numerous schools around the world and found that children exposed to WiFi, report the same symptoms reported back in 1932: fatigue, headaches, nausea, chest pain and vision problems.

In the document he provided to the King of Botswana, Trower mentions that his research reveals that both children and women are more vulnerable to disease caused by exposure to radiation such as the kind emitted by Wi Fi and microwave. “Children have less dense bones, immature immune systems and, by virtue of their size, they can act as aerials. Females have more complex hormone based systems to be disrupted than males.” he adds.

Indeed, governments have kept this information hidden for over 40 years now. They learned about the dangers of Wi Fi and microwave radiation for decades and chose not to say anything fearing that the profits that corporations have accumulated through the sale of Wi Fi technology and all the products and services that originated from it. Mr. Trower’s research as well as the documents obtained through the Freedom of Information requests should be sufficient proof beyond reasonable doubt that this technology has been used not only to get people addicted to it, but also to cause mass disease for decades. “They’re afraid of lawsuits if they admit this is dangerous.” Fortunately, they do not need to admit such dangers in order for legal action to be taken. It wouldn’t be strange to see lawsuits popping up as a consequence of Dr. Trower’s revelations. Both governments and technology companies must be held accountable for collaborating with the mass poisoning of humanity and all other forms of life.

Sleep Deprived? Avoid Using Nuvigil

Pricey Nuvigil competes with coffee—and has a lot more side effects. Nuvigil “may lead to limited physical or psychological dependence…” Cephalon also reports plenty of side effects ranging from headache, nausea, skin rashes, hallucinations and depression.

By
Bloomberg
August 14, 2011

Roger Greer, a 45-year-old water treatment plant worker from Coatesville, Pa., was surfing the Internet when he discovered that his constant fatigue had a medical name: shift work sleep disorder. The starting time of Greer’s job rotates weekly, leaving him sleepy on the job and ornery at home. The website had an ad suggesting he ask his doctor if an alertness pill made by Cephalon (CEPH), called Nuvigil, is right for him. A year later, “I don’t have those sleepy moments,” says Greer. “Now at 3 in the morning, the absolute worst time for anybody, I no longer have the fear of missing something here at work.”

Workers like Greer are prime targets for a Cephalon marketing campaign—on the Internet and radio, in doctors’ offices, and at community meetings—that aims to educate America’s 15 million shift workers about the disorder. For the drug maker, it’s a way to build brand recognition and sales for Nuvigil, a newer version of its blockbuster narcolepsy drug, Provigil, which loses patent protection next year. But the campaign has sparked concern by some doctors about whether a pharmaceutical solution is the best way to stay alert on the job. Nuvigil hasn’t been proved more effective than coffee, is classified as possibly addictive, and carries side effects that can be fatal, according to the drug’s label.

“We as a society rely too much on pills and medication,” says Robert Basner, director of Columbia University’s Cardiopulmonary Sleep and Ventilatory Disorders Center. “That’s not always the best approach. Caffeine is a very good wake-promoting agent, and it’s a lot cheaper.”

Cephalon is spending $3.6 million on radio ads pitching Nuvigil, plus about $490,000 annually on the Internet effort and informational booths at community events. That’s a small percentage of the $1.1 billion in annual sales that will be at risk after Provigil goes off-patent. Israel’s Teva Pharmaceutical Industries (TEVA) agreed in May to buy Cephalon for $6.2 billion in part because of Nuvigil’s prospects. The drug’s sales are growing at a 50 percent annual rate.

Bethany Young, a 27-year-old Teas Valley (W. Va.) medical technologist, was given free samples of Nuvigil after complaining to her new doctor that she couldn’t focus during her 7 p.m. to 7 a.m. hospital shifts. During six years of night work, she struggled to get out of bed, gained 60 pounds, and developed hypothyroidism. At first the drug made her feel euphoric. Soon that effect began to melt away after an hour, replaced by feelings of anxiety and stress, she says, and when she tried to stop using it after a few months, she initially couldn’t. “I was getting hooked on it. I couldn’t quit. This drug is the devil. It was for me, anyway.”

Cephalon says that because medications like Nuvigil “may lead to limited physical or psychological dependence, we encourage physicians to follow patients closely.” The company also reports plenty of side effects that can accompany Nuvigil use, ranging from headache, nausea, and skin rashes to hallucinations and depression.

Cephalon’s media campaign is its first to widely trumpet alertness pills by stressing the recognition of shift work disorder by doctors and sleep experts, who estimate the malady may affect one in four shift workers. Although Cephalon doesn’t claim Nuvigil works better than other approaches, the company says that between 2007 and 2009 it studied 359 shift workers for six weeks and found 77 percent of those who took Nuvigil said they were more alert for the last part of their shift and the drive home, compared with 57 percent given a placebo.

“What we are doing is educating doctors and the public about this disorder,” says Charles Altman, Cephalon’s senior medical director. “Doctors often don’t ask patients what hours they work. In our 24/7 society, it doesn’t matter if you are a nurse or an information technology worker or in finance, we are called upon more and more to work odd hours that are against the grain of the way our internal clock works.”

Critics, however, say the diagnosis of shift work sleep disorder is so broad that people with irregular hours who have trouble staying awake at night can get the pills even without trying non-drug strategies first. “It’s not a diagnosis that is crisp and determined by clear-cut, objective data, which opens it up to criticism,” says Lois Krahn, chair of psychiatry at the Mayo Clinic in Scottsdale, Ariz. “When [patients] have done everything they can to get more sleep, and they still have trouble staying awake, that’s when drug therapy comes in.”

Besides the ad push, Cephalon is using pricing to lure users. At $12 a pill, Nuvigil sells for $5 less than its older sibling. Cephalon also is providing consumers with coupons for free trials and help with insurance co-pays to spur use of the newer drug. The strategy is paying off, with the number of Nuvigil prescriptions written in late June almost equaling those for Provigil. “It’s growing very nicely,” says Cephlon’s Altman.

Provigil was first approved for sale in 1998 as a treatment for narcolepsy, a rare condition in which patients unexpectedly fall asleep in the middle of the day. Provigil kept them awake, without the dangers of stimulants. Sales, which surged as people without the condition also used it, topped $500 million annually after the pill won clearance for shift work disorder in 2004. Nuvigil was introduced in 2009, two years after it was approved for narcolepsy, shift work disorder, and sleep apnea. It had sales of $186 million in 2010, and analysts say it could hit $577 million in 2015.

Sleep experts say Cephalon’s radio ads in 21 big U.S. cities may educate patients with symptoms that employers and family members often don’t understand. Still, doctors say simply handing struggling shift workers a prescription would be a mistake without trying lifestyle changes, such as strategic naps or wearing sunglasses on the drive home to limit exposure to light. Explains Douglas Moul, staff physician at the Cleveland Clinic Sleep Center: “We want to treat the real condition, rather than just papering over the symptoms with a medication that can just keep people awake longer.”

The bottom line: Sales of Cephalon’s shift work disorder drug, Nuvigil, are growing 50 percent annually. Critics say the pills may be overprescribed.